NCT06277050: Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma |
|
|
| Recruiting | 3 | 264 | RoW | Maintenance Therapy with Toripalimab and Capecitabine, Maintenance Therapy with Capecitabine | Jiangxi Provincial Cancer Hospital | Nasopharyngeal Carcinoma, High-Risk Cancer, Maintenance Therapy | 02/29 | 02/30 | | |
NCT04557020: Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC |
|
|
| Recruiting | 3 | 200 | RoW | PD-1 antibody, Gemcitabine, Cisplatin, IMRT | Jiangxi Provincial Cancer Hospital | Nasopharyngeal Carcinoma | 03/26 | 03/26 | | |
NCT05126719: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 238 | RoW | MRG003, Capecitabine tablets, Docetaxel injection | Shanghai Miracogen Inc. | Recurrent or Metastatic Nasopharyngeal Carcinoma | 10/24 | 02/25 | | |
NCT06221618: Evaluation of Vascular Structure in Elderly Using High-frequency Ultrasound and Construction of a Multimodal Risk Assessment System for Cardiovascular Diseases: a Multicenter Study |
|
|
| Not yet recruiting | N/A | 8000 | RoW | High-frequency carotid arteries ultrasound, CCTA, Cranial MRA | Qilu Hospital of Shandong University, Chinese PLA General Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Xuanwu Hospital, Beijing, Shenzhen People's Hospital, Shenzhen University, The Fourth Affiliated Hospital of China Medical University | Atherosclerosis, Stroke, Coronary Disease | 10/25 | 12/25 | | |
